Product Images Divalproex Sodium

The text is describing the % reduction in CPS (central pain syndrome) rate for two types of divalproex sodium tablets. It shows a chart with the % of patients experiencing improvement, no change, or worsening of their condition. No further information or context is provided.*

This is a medication called Divalproex Sodium which is an extended-release tablet that contains valproic acid. It is used for daily dosing and the usual dosage information can be found in the package insert. It should be stored in a tight and light-resistant container at a controlled room temperature. The medication is manufactured by Cadlla Healthcare Ltd in Ahmedabad, India, and distributed by Zydus Pharmaceuticals USA Inc in Pennington, NJ. Pharmacists should dispense the medication guide to each patient and caution should be taken to keep it out of reach of children.*

NDC 68382-134-01 is an extended-release version of valproex sodium. Each tablet contains divalproex sodium, USP equivalent to valproic acid 500 mg. The medication guide should be provided to each patient. This medicine should be stored at 20° to 25°C (66° o 77°F) in a tightly closed, light-resistant container. It should be kept out of reach of children. It is manufactured by Cadlla Healthcare Ltd in Ahmedabad, India, and distributed by Zydus Pharmaceuticals USA Inc. in Pennington, NJ 08534. Please see the package insert for complete prescribing information.*